Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
affirming, agonist, AstraZeneca, austerity, banc, Berlin, Boehringer, brain, burdensome, buying, calendar, capacity, Chemie, Colin, compatible, compelling, constantly, cut, dapagliflozin, denominated, device, dialog, digital, empagliflozin, en, encourage, Endo, Euro, facilitate, Farxiga, Glyxambi, Guy, hunger, Ingelheim, invoice, Jardiance, Kastelstein, Maestro, Marsh, Memorandum, Mezzion, month, narrow, nerve, obstructive, older, OSA, panel, percent, petition, pharmacotherapy, population, post, realignment, receptor, Rechargeable, rehear, rejected, removal, repayment, reserve, resolution, route, Samuel, Saxenda, sequestration, slated, speak, Squibb, stomach, supersede, tendency, Teva, unasserted, unique, unmet, USA, variation, waiver, website, weighed
Removed:
achievement, acuity, annually, ASC, assessing, assumption, CIV, Codification, color, commit, database, discrimination, element, ensuing, feasible, foregoing, healthy, hearing, HRSA, intraocular, likelihood, male, men, mild, modest, multicenter, negotiate, Newer, noncancelable, parallel, planning, pressure, prudent, pupillometry, randomized, recording, recoverable, reliably, sensitivity, showing, space, staffing, topic, track, vacated, vision, visual
Filing tables
Filing exhibits
Related press release
VVUS similar filings
Filing view
External links